(Q46762219)

English

Fluvoxamine as a sigma-1 receptor agonist improved cognitive impairments in a patient with schizophrenia

scientific article published on 16 January 2008

Statements

Fluvoxamine as a sigma-1 receptor agonist improved cognitive impairments in a patient with schizophrenia (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit